Tarbox Family Office’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33
Closed -$2K 880
2022
Q1
$2K Buy
33
+15
+83% +$1.08K ﹤0.01% 857
2021
Q4
$2K Hold
18
﹤0.01% 932
2021
Q3
$2K Hold
18
﹤0.01% 973
2021
Q2
$3K Sell
18
-7
-28% -$1.13K ﹤0.01% 855
2021
Q1
$5K Hold
25
﹤0.01% 583
2020
Q4
$5K Buy
25
+21
+525% +$4.27K ﹤0.01% 545
2020
Q3
$1K Hold
4
﹤0.01% 1065
2020
Q2
$1K Hold
4
﹤0.01% 1067
2020
Q1
$1K Buy
+4
New +$465 ﹤0.01% 995

Other funds holding TDOC

Tarbox Family Office's TDOC Position: Q2 2022 in Review

Tarbox Family Office sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 33 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $5K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Tarbox Family Office reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 33 Teladoc Health shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Teladoc Health position peaked at $5K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.